Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 1/28/16  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Richard E. Chaisson

Wrong Dr. Richard E. Chaisson?


Phone: (410) ***-****  
Email: r***@***.edu
Local Address:  Baltimore , Maryland , United States
J. Hillis Miller Health Center
1600 SW Archer Road Room M 452 MSB
Gainesville , Florida 32610
United States


Employment History

Board Memberships and Affiliations


  • M.D.
  • MD degree
    University of Massachusetts
  • BS Degree
    University of Massachusetts
  • MD
183 Total References
Web References
HIVGR1,2 & 3 PROGRAM INFO (SPEAKERS, CME INFO, DISCLOSURES) : ViralEd, Inc., 16 Dec 2015 [cached]
Richard E. Chaisson, MD JHU
Richard E. Chaisson, MD
Professor of Medicine Director, Center for Tuberculosis research Director, Center for AIDS Research Johns Hopkins University School of Medicine
Richard E. Chaisson MD
Richard E. Chaisson MD
In an editorial accompanying the study, ... [cached]
In an editorial accompanying the study, Johns Hopkins infectious disease specialists Richard Chaisson, M.D., and Eric Nuermberger, M.D., call the proliferation of the drug-resistant organisms an "enormous challenge" to eradicating TB, which now kills 1.5 million people each year, mostly in the developing world.
More worrisome among the study findings, says Chaisson, a professor at the Johns Hopkins University School of Medicine and founding director of its Center for Tuberculosis Research, was that the majority of the estimated 110,000 drug-resistant cases occurred among people newly diagnosed with TB, indicating that these drug-resistant bacteria were transmitted from one person to another. Only 3 percent of all newly detected cases were tested for drug resistance.
This research, Chaisson says, "upsets the old dogma" that drug-resistant organisms occur mostly in people who fail to respond to therapy or in infected people who relapse after drug treatment. In sum, he says, drug resistance appears to be present in new cases on a large scale, and drug-resistance testing should not be limited to previously treated patients.
Chaisson says the study also highlights the urgent need for faster testing of those newly diagnosed to determine drug resistance. Current laboratory testing methods, while relatively cheap (at less than $5 per person), take several weeks to show bacterial growth in sputum samples. Same-day results are available using high-tech, molecular assays, but they dramatically raise the test cost to as much as $40 per person, a cost he says is worth it, given the "sobering" scope of the problem.
According to Chaisson, multidrug resistant strains of TB cannot be effectively treated by either of the two most commonly used antibiotics, isoniazid and rifampin.
Chaisson and Nuermberger point out that individual drug studies are required by U.S. and global regulatory agencies.
The idea of paying people to ..., 17 Jan 2016 [cached]
The idea of paying people to encourage medical care isn't new, said Dr. Richard Chaisson, director of the Johns Hopkins Center for Tuberculosis Research in Baltimore.
"It works," Chaisson said. "Generally, if you pay people to get discrete things like a test, they'll do it."
However, such incentives usually aren't necessary when tuberculosis erupts in the United States, he said.
"Last year here in Maryland we had two different situations where students were exposed at schools," he said.
Our Staff | CREATE | Consortium to Respond Effectively to the AIDS / TB Epidemic, 15 June 2013 [cached]
Richard Chaisson
Richard Chaisson
CREATE Principal Investigator
Director, Johns Hopkins University Center for Tuberculosis Research
Research Consortium Receives $44.7 Million Gates Foundation Grant to Evaluate New Strategies to Fight HIV-Related Tuberculosis - Bill & Melinda Gates Foundation, 1 Jan 2004 [cached]
"TB and HIV form a lethal combination, each amplifying the other's progress," said Richard Chaisson, MD, Professor of Medicine at Johns Hopkins University and principal investigator of CREATE.
Other People with the name "Chaisson":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.